Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
US6964759B2 · kind B2 · utility
34Cited by
33References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2001 |
| Grant date | Nov 15, 2005 |
| Priority date | — |
| Expiry date | Feb 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations for the administration through pressurized metered dose aerosol inhalers containing an anticholineric drug in solution in a hydrofluorocarbon propellant, a cosolvent and a low volatility component, and the use thereof in chronic obstructive pulmonary disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.